Literature DB >> 18838343

Liposomes targeted by fusion phage proteins.

Prashanth K Jayanna1, Vladimir P Torchilin, Valery A Petrenko.   

Abstract

Targeting of nanocarriers has long been sought after to improve the therapeutic indices of anticancer drugs. Here we provide the proof of principle for a novel approach of nanocarrier targeting through their fusion with target-specific phage coat proteins. The source of the targeted phage coat proteins are landscape phage libraries--collections of recombinant filamentous phages with foreign random peptides fused to all 4000 copies of the major coat protein. We exploit in our approach the intrinsic physicochemical properties of the phage major coat protein as a typical membrane protein. Landscape phage peptides specific for specific tumors can be obtained by affinity selection, and purified fusion coat proteins can be assimilated into liposomes to obtain specific drug-loaded nanocarriers. As a paradigm for inceptive experiments, a streptavidin-specific phage peptide selected from a landscape phage library was incorporated into approximately 100-nm liposomes. Targeting of liposomes was proved by their specific binding to streptavidin-coated beads.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838343      PMCID: PMC2819096          DOI: 10.1016/j.nano.2008.07.006

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  40 in total

Review 1.  The use of phage display for the development of tumour targeting agents.

Authors:  F Nilsson; L Tarli; F Viti; D Neri
Journal:  Adv Drug Deliv Rev       Date:  2000-09-30       Impact factor: 15.470

2.  Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.

Authors:  O P Medina; T Söderlund; L J Laakkonen; E K Tuominen; E Koivunen; P K Kinnunen
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

3.  Structure and dynamics of a membrane protein in micelles from three solution NMR experiments.

Authors:  Sangwon Lee; Michael F Mesleh; Stanley J Opella
Journal:  J Biomol NMR       Date:  2003-08       Impact factor: 2.835

4.  Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells.

Authors:  Peter Hölig; Miriam Bach; Tina Völkel; Thomas Nahde; Sven Hoffmann; Rolf Müller; Roland E Kontermann
Journal:  Protein Eng Des Sel       Date:  2004-07-02       Impact factor: 1.650

5.  A library of organic landscapes on filamentous phage.

Authors:  V A Petrenko; G P Smith; X Gong; T Quinn
Journal:  Protein Eng       Date:  1996-09

6.  Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.

Authors:  Fabio Pastorino; Chiara Brignole; Daniela Di Paolo; Bice Nico; Annalisa Pezzolo; Danilo Marimpietri; Gabriella Pagnan; Federica Piccardi; Michele Cilli; Renato Longhi; Domenico Ribatti; Angelo Corti; Theresa M Allen; Mirco Ponzoni
Journal:  Cancer Res       Date:  2006-10-15       Impact factor: 12.701

7.  Neuroblastoma tumor cell-binding peptides identified through random peptide phage display.

Authors:  J Zhang; H Spring; M Schwab
Journal:  Cancer Lett       Date:  2001-10-10       Impact factor: 8.679

8.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.

Authors:  V P Torchilin; T S Levchenko; A N Lukyanov; B A Khaw; A L Klibanov; R Rammohan; G P Samokhin; K R Whiteman
Journal:  Biochim Biophys Acta       Date:  2001-04-02

9.  Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes.

Authors:  S Zalipsky
Journal:  Bioconjug Chem       Date:  1993 Jul-Aug       Impact factor: 4.774

Review 10.  Selective targeting of cancer cells using synthetic peptides.

Authors:  Mohsen Shadidi; Mouldy Sioud
Journal:  Drug Resist Updat       Date:  2003-12       Impact factor: 18.500

View more
  25 in total

1.  Evolutionary selection of new breast cancer cell-targeting peptides and phages with the cell-targeting peptides fully displayed on the major coat and their effects on actin dynamics during cell internalization.

Authors:  Gopal Abbineni; Sita Modali; Barbara Safiejko-Mroczka; Valery A Petrenko; Chuanbin Mao
Journal:  Mol Pharm       Date:  2010-08-25       Impact factor: 4.939

Review 2.  Combinatorial peptide libraries: mining for cell-binding peptides.

Authors:  Bethany Powell Gray; Kathlynn C Brown
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

3.  Mutations in fd phage major coat protein modulate affinity of the displayed peptide.

Authors:  G A Kuzmicheva; P K Jayanna; A M Eroshkin; M A Grishina; E S Pereyaslavskaya; V A Potemkin; V A Petrenko
Journal:  Protein Eng Des Sel       Date:  2009-07-25       Impact factor: 1.650

Review 4.  Virus-based chemical and biological sensing.

Authors:  Chuanbin Mao; Aihua Liu; Binrui Cao
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

5.  Landscape phage ligands for PC3 prostate carcinoma cells.

Authors:  P K Jayanna; D Bedi; P Deinnocentes; R C Bird; V A Petrenko
Journal:  Protein Eng Des Sel       Date:  2010-02-25       Impact factor: 1.650

6.  On the mechanism of targeting of phage fusion protein-modified nanocarriers: only the binding peptide sequence matters.

Authors:  Tao Wang; Nikita Kulkarni; Gerard G M D'Souza; Valery A Petrenko; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2011-07-29       Impact factor: 4.939

7.  Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein.

Authors:  Tao Wang; Shenghong Yang; Valery A Petrenko; Vladimir P Torchilin
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

8.  Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein.

Authors:  Tao Wang; Gerard G M D'Souza; Deepa Bedi; Olusegun A Fagbohun; L Prasanna Potturi; Brigitte Papahadjopoulos-Sternberg; Valery A Petrenko; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

9.  Engineering chemically modified viruses for prostate cancer cell recognition.

Authors:  K Mohan; G A Weiss
Journal:  Mol Biosyst       Date:  2015-12

10.  Targeted delivery of siRNA into breast cancer cells via phage fusion proteins.

Authors:  Deepa Bedi; James W Gillespie; Vasily A Petrenko; Andreas Ebner; Michael Leitner; Peter Hinterdorfer; Valery A Petrenko
Journal:  Mol Pharm       Date:  2013-01-08       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.